Scientists have determined the structure of a third subtype of botulinum neurotoxin — a deadly toxin that causes the disease botulism, and is also used in cosmetic and therapeutic applications. The structure reveals a unique arrangement of the active components that may help explain why subtype E is faster-acting than others — and may have implications for improving vaccines and/or therapeutic agents.